Dr. Kevin Anthony Quann, MD, PhD

Dr. Quann practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Quann's NPI, 1154784080, was assigned on March 29, 2016. Dr. Quann holds Pennsylvania license MD466055.

Dr. Quann's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Quann's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Quann is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Quann to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quann practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Quann's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Quann is licensed in Pennsylvania.

CMS data shows 167 Medicare services from Dr. Quann across 2 procedure codes in 2024, for 46 Medicare patients. Medicare paid $11,958 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 46 Medicare patients who saw Dr. Quann in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quann's median patient age at 69, with 38% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Quann for performance year 2024, reported as part of a group. Dr. Quann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Quann, published from 2011 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Caveolin 1, Cell Line, Tumor and Down-Regulation. Dr. Quann has published most often in Cell Cycle. Dr. Quann's most frequent co-authors are Mounzer E. Agha, MD, Kathleen Anne Dorritie, MD and Annie Pearl Im, MD.

CMS Open Payments shows 10 general payments to Dr. Quann from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 80% of the total. Amgen Inc. paid the most, $519.